Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Finasteride treatment in male rats can reduce fertility and affect sperm development in their offspring.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride causes sperm production decrease in Mesocricetus auratus.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Older men have different fertility histories and factors affecting fertility, suggesting they may benefit from earlier fertility evaluations.

Age is more important than BMI for IVF success in women with infertility and PCOS.

Long-term finasteride use may affect sperm structure and chromosomes.

Severe iron deficiency lowers fertility in female rats.

DHT deficiency in rats reduces sperm content and affects testis structure over time.

Polycystic ovary syndrome causes high male hormone levels, leading to symptoms like excess hair, acne, and fertility problems.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Finasteride and testosterone are the drugs most linked to male infertility, but many other potential drugs may be under-reported.

Some skin diseases and their treatments can negatively affect male fertility.

A woman with a specific mutation causing adrenal gland issues faced fertility problems, but careful hormone therapy helped her manage it successfully.

Women with nonclassical congenital adrenal hyperplasia may have a higher risk of fertility issues and miscarriages, and should get genetic counseling.

Short-term finasteride use likely doesn't harm male fertility.

Women with pituitary adenomas often have reproductive issues, like irregular periods and trouble getting pregnant, but not always breast milk production without pregnancy.

Hyperprolactinemia is the most common cause of secondary amenorrhea, followed by drug use.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Testicular microlithiasis may increase the risk of testicular cancer and patients with it should be closely monitored.

PRP injections may slightly improve hair density and count for male hair loss, but more research is needed.

Adrenal disorders often cause high blood pressure in young people.

The case shows skin changes can indicate deeper health issues like insulin resistance, which are challenging to manage.

Chrousos Syndrome is caused by mutations that make the body less sensitive to glucocorticoids, leading to various symptoms and requiring high-dose treatment.

PCOS is a major cause of infertility in women of childbearing age.

AMH helps estimate ovarian reserve but doesn't predict pregnancy chances; age is more important.

Hair loss in postmenopausal women due to ovarian hyperthecosis is rare, but removing the ovaries can significantly improve the condition.